{"title":"Exercise-induced Hypertension and Cardiovascular Remodeling in Middle-aged Male Marathon Runners: A Narrative Review.","authors":"Ivan Bocharin","doi":"10.2174/0115734021537103261030094404","DOIUrl":"https://doi.org/10.2174/0115734021537103261030094404","url":null,"abstract":"<p><strong>Background: </strong>Regular aerobic exercise is a cornerstone of cardiovascular disease prevention, but the growing participation of middle-aged men in marathon and ultramarathon running raises concerns about the interplay between endurance training, blood pressure regulation, and cardiac remodeling. Exercise-induced hypertension, defined as an exaggerated blood pressure response to physical exertion, has emerged as an important but underrecognized risk factor in this populación. This narrative review aims to summarize current evidence on the relationship between exercise-induced hypertension, arterial stiffness, and cardiovascular remodeling in amateur male marathon runners aged 35-50 years, and to define the boundaries between physiological adaptation and hypertensiondriven pathological restructuring of the myocardium.</p><p><strong>Methods: </strong>A narrative review of the literature (2010-2026) was conducted using PubMed, Scopus, and Web of Science. Studies employing office and ambulatory blood pressure monitoring, echocardiography (including septal geometry and indices of diastolic function), cardiac magnetic resonance imaging, arterial stiffness assessment, and cardiac biomarker analysis (including sST2 and galectin- 3) in endurance-trained non-professional athletes were included.</p><p><strong>Results: </strong>Moderate aerobic training reduces resting blood pressure and improves endothelial function, whereas excessive workloads exceeding 100-120 km per week are associated with exaggerated exercise blood pressure responses, increased arterial stiffness, atrial fibrillation, and myocardial fibrosis. Amateur marathon runners frequently exhibit transient elevation of conventional cardiac biomarkers, as well as post-race increases in fibrosis-related biomarkers (sST2, galectin-3) and reversible myocardial strain reduction. Exercise-induced hypertension is associated with early echocardiographic signs of hypertensive remodeling, including septal bulge formation and subclinical diastolic dysfunction (elevated E/e' ratio).</p><p><strong>Discussion: </strong>Exercise-induced hypertension appears to be a mechanistic link between chronic highvolume endurance training and adverse cardiac remodeling, particularly in middle-aged men with subclinical vascular aging or latent hypertension.</p><p><strong>Conclusion: </strong>Individualized blood pressure screening, monitoring of arterial stiffness, and structured recovery are essential for safe marathon participation in men aged 35-50 years.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149411702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Improving Compliance/Adherence with Antihypertensive Treatment is a Clinical and Health System Priority.","authors":"Bojan Jelakovic, Ana Jelakovic, Guido Grassi","doi":"10.2174/0115734021511267261008104057","DOIUrl":"https://doi.org/10.2174/0115734021511267261008104057","url":null,"abstract":"","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Conference Report The 35th European Society of Hypertension Meeting, GDANSK, May 28-31, 2026.","authors":"Guido Grassi","doi":"10.2174/011573402110265260915092650","DOIUrl":"https://doi.org/10.2174/011573402110265260915092650","url":null,"abstract":"","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149325825","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ba Nam Nguyen, Cuong Le, Huong Duong, Khue La, Tuan Nguyen, Quang La
{"title":"Treatment Adherence and Associated Factors Among Hypertensive Patients in Can Tho City, Vietnam: a Cross-sectional Study.","authors":"Ba Nam Nguyen, Cuong Le, Huong Duong, Khue La, Tuan Nguyen, Quang La","doi":"10.2174/0115734021501463261007104548","DOIUrl":"https://doi.org/10.2174/0115734021501463261007104548","url":null,"abstract":"<p><strong>Introduction: </strong>Hypertension control depends strongly on treatment adherence, yet adherence remains suboptimal in many low- and middle-income countries. Addressing suboptimal hypertension treatment adherence is a public health priority in developing countries like Vietnam. This study aimed to determine the level of treatment adherence and identify factors associated with nonadherence to hypertension treatment among patients in Can Tho City, Vietnam.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among 434 hypertensive patients managed at commune health stations in Can Tho City, Vietnam, in 2022. Treatment adherence was assessed across six domains, including medication adherence (MMAS-8), diet, smoking cessation, alcohol restraint, physical activity, and follow-up monitoring. Multivariable logistic regression was used to identify factors associated with non-adherence.</p><p><strong>Results: </strong>Overall treatment adherence was 45.6%. Medication adherence was 59.0%, whereas adherence to follow-up monitoring was 48.8%. Female patients demonstrated significantly higher overall treatment adherence than males (55.5% vs. 30.4%, p < 0.001). In multivariable analyses, male sex, lack of health insurance, poor patient-doctor relationship, and not actively seeking hypertensionrelated information were independently associated with non-adherence. Sex-stratified analyses further identified differences in factors associated with non-adherence between men and women. In addition, patients with treatment adherence had significantly lower systolic and diastolic blood pressure than non-adherent patients.</p><p><strong>Discussion: </strong>Treatment adherence among hypertensive patients remained suboptimal. Poor patientdoctor relationship was consistently associated with non-adherence, while factors associated with non-adherence differed between men and women. Better treatment adherence was also associated with lower blood pressure.</p><p><strong>Conclusion: </strong>Treatment adherence among hypertensive patients in Can Tho City remained suboptimal. Interventions focusing on strengthening patient-doctor relationships, improving patient education and engagement, and reducing financial barriers may improve long-term treatment adherence and hypertension management.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149185126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Badia Al Outmani, Asmae Yeznasni, Naima Abda, Zakaria Bazid, Nabila Ismaili, Noha El Ouafi
{"title":"Therapeutic Inertia in the Management of Hypertension by Moroccan General Practitioners.","authors":"Badia Al Outmani, Asmae Yeznasni, Naima Abda, Zakaria Bazid, Nabila Ismaili, Noha El Ouafi","doi":"10.2174/0115734021447979260925070423","DOIUrl":"https://doi.org/10.2174/0115734021447979260925070423","url":null,"abstract":"<p><strong>Background: </strong>Therapeutic inertia has been identified as a major factor in poor blood pressure control. This study aimed to investigate factors associated with therapeutic inertia in hypertension management among Moroccan General Practitioners (GPs).</p><p><strong>Methods: </strong>A descriptive and analytical cross-sectional study was conducted from October 2021 to January 2022, involving Moroccan general practitioners using an anonymous questionnaire developed specifically for this study, covering numerous areas: their socio-demographic characteristics, assessment of hypertension knowledge, reasons not to intensify therapy, and clinical scenarios. A univariate analysis was performed using the Chi-square test to compare percentages. A multivariable logistic regression analysis was also applied to study variables possibly associated with therapeutic inertia.</p><p><strong>Results: </strong>A total of 130 physicians participated in this study. Most of the practitioners were female (62.3%). The median age was 32 years (IQR, 26-50). The percentage of physicians who had practiced for 5 years or less was 51.5%, compared with 48.5% who had practiced for more than 5 years. The median number of patients seen per day was estimated at 30 patients with an interquartile range of [15, 50]. The median consultation duration was 10 minutes (IQR, 5-15). Using the study-defined cutoff of ≥2, 78.5% of physicians met the criterion for therapeutic inertia (95% CI, 70.4%-85.2%). Furthermore, the two main reasons for therapeutic abstention reported by physicians were: the importance of improving patient compliance, lifestyle, and dietary measures before intensifying treatment (81.5%), in addition to the perception that office blood pressure does not reflect the patient's \"true\" blood pressure (BP) and therefore does not support immediate treatment intensification without further ambulatory monitoring (43.8%).</p><p><strong>Discussion: </strong>This study found a high prevalence of therapeutic inertia in primary care. The study's results found that the advanced age of the hypertensive patient was inversely related to clinical inertia. Multivariable regression showed that when the patient is diabetic, the general practitioners tend to be 4 times more 'therapeutically inert' [OR 4.42 (95% CI 1.2-7.23)]. A patient's history of ischemic stroke was also positively associated with Therapeutic Inertia (TI) [OR 1.53 (95% CI 1.23-4.23)].</p><p><strong>Conclusion: </strong>Therapeutic inertia was common among participating Moroccan general practitioners and varied across clinical contexts. According to our study, the history of diabetes or stroke was positively associated with inertia. Given the exploratory nature of the study and its sampling limitations, these findings require confirmation in larger and more representative studies.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149168969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical Efficacy of Polypill with a Focus on Blood Pressure Control: A Systematic Review and Meta-analysis.","authors":"Andrey Garanin, Olesya Aydumova, Anatoly Rubanenko","doi":"10.2174/0115734021483573260921051313","DOIUrl":"https://doi.org/10.2174/0115734021483573260921051313","url":null,"abstract":"<p><strong>Introduction: </strong>The effectiveness of controlling blood pressure when prescribing a fixed combination (\"polypill\") compared to monocomponent drugs has not been fully determined. According to the studies conducted, some demonstrate statistically significant differences in mean blood pressure levels when taking a \"polypill\" compared to monocomponent drugs, while others do not reveal this effect. The aim was to evaluate the efficacy of \"polypill\" in lowering blood pressure in patients with Cardiovascular (CV) diseases compared to monocomponent drugs.</p><p><strong>Methods: </strong>The search was conducted according to PRISMA guidelines in PubMed, Google Scholar, and ClinicalTrials databases. Finally, 10 studies were selected. The dynamics of the mean systolic and diastolic pressure in patients taking \"polypill\" was evaluated in comparison to monocomponent drugs.</p><p><strong>Results: </strong>During the identification stage, 568 publications were found. At the screening phase, 321 papers, such as books, reviews, systematic reviews, meta-analyses, etc were excluded. 168 papers were assessed for eligibility. After the eligibility assessment, 158 papers were excluded for deviations from the study design (e.g., no control group, no direct comparison between \"polypill\" and monocomponent drug therapy, data presented as median and interquartile range, placebo as the control group, etc.). In the final analysis, we included 10 publications that evaluated the effect of a fixed combination of medications (\"polypill\") compared with monocomponent therapy on blood pressure. During further sub-analyses, 1 study was excluded. The meta-analysis of the clinical efficacy of \"polypill\" control of blood pressure was conducted in comparison with standard therapy and comprised 9 studies, involving patients with previous myocardial infarction, acute cerebrovascular accident, high CV risk, hypertension and dyslipidemia. In total, all of the studies enrolled 6264 people, of whom 3147 patients received \"polypill\", and 3117 patients - monocomponent drugs. The meta-analysis demonstrated that fixed-dose combination therapy yielded a statistically significant difference compared to standard therapy with respect to its impact on systolic (standardized mean difference: -0.128; (-0.177; -0.08); p < 0.01) and diastolic (standardized mean difference: -0.171; (-0.233; -0.11); p < 0.01) blood pressure.</p><p><strong>Discussion: </strong>The findings of the conducted meta-analysis support the evidence of beneficial switching to \"polypill\" therapy in patients with hypertension, especially in cases requiring a multi-drug regimen.</p><p><strong>Conclusion: </strong>\"Polypill\" therapy in patients with CV diseases, hypertension, dyslipidemia, and high CV risk is associated with more effective blood pressure control compared to monocomponent drugs.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149138708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Review Highlighting Emerging Frontiers in Hypertension Management: Integrating Novel Therapeutics and Holistic Approaches.","authors":"Nishant Gaurav, Sumita Singh, Vishal Kumar Biswkarma","doi":"10.2174/0115734021472294260830065452","DOIUrl":"https://doi.org/10.2174/0115734021472294260830065452","url":null,"abstract":"<p><p>Despite the availability of various antihypertensive medications, hypertension (HTN) remains a major global cause of heart disease, stroke, renal damage, and early mortality. This narrative summary describes current advances and new directions in HTN treatment beyond prescription drugs. We used PubMed, Scopus, Web of Science, and Google Scholar to conduct a comprehensive literature search for papers published between 2000 and 2026. A careful evaluation and combination of pertinent clinical trials, systematic reviews, meta-analyses, international recommendations, and important research about innovative blood pressure therapies, device-based interventions, digital health tools, personalized medicine, and advances in public health were conducted. In addition to highlighting novel pharmacological treatments such as aldosterone synthase inhibitors, RNA interference- based medicines, and endothelin pathway regulators, this study examines the shortcomings of traditional blood pressure drugs. Device-based methods, such as renal denervation and baroreceptor activation therapy, along with digital therapeutics, remote healthcare, wearable monitoring equipment, and AI-supported clinical decision-making tools, are also being explored. Additionally, personalized medicine strategies involving genetics, metabolomics, biomarker-directed treatment, lifestyle improvements, and public health programs, including WHO HEARTS and India IHCI, are discussed. While many emerging strategies show promising results in reducing blood pressure, significant constraints persist regarding evidence of long-term cardiovascular outcomes, cost, availability, and applicability across varied populations. Future HTN management will likely require integrated, patient-focused, technology-driven, and precision-guided approaches to achieve lasting and equitable cardiovascular risk reduction worldwide.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148971713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preeclampsia-associated Biomarkers and their Potential Relevance to Stillbirth Risk: A Tutorial Review.","authors":"Alycia Devasagayam, Stalin Selvaraj","doi":"10.2174/0115734021496393260828062926","DOIUrl":"https://doi.org/10.2174/0115734021496393260828062926","url":null,"abstract":"<p><p>Stillbirth remains a major global public health challenge, accounting for nearly two million deaths annually despite significant advances in antenatal and obstetric care. Reliable biomarkers for its early prediction are still lacking, highlighting the need to identify novel diagnostic strategies. Since preeclampsia and stillbirth share several underlying pathophysiological mechanisms, including placental insufficiency, impaired trophoblast invasion, endothelial dysfunction, angiogenic imbalance, oxidative stress, and systemic inflammation, biomarkers established for preeclampsia may also hold promise for stillbirth risk assessment. This tutorial review summarizes current evidence on protein- and metabolome-based biomarkers used for the early diagnosis of preeclampsia and evaluates their potential applicability for predicting stillbirth. A comprehensive literature search of Scopus, PubMed, and ScienceDirect was conducted for studies published between 2010 and 2024. Conventional fetal monitoring techniques such as ultrasonography, magnetic resonance imaging (MRI), and cardiotocography (CTG) remain valuable for assessing fetal well-being but offer limited predictive accuracy for stillbirth. Several biomarkers, including angiogenic factors (sFlt-1, PLGF, sEng), placental proteins (PP13, PAPP-A), cardiovascular markers (BNP, NT-proBNP), renal biomarkers (cystatin C), metabolic markers (uric acid), and emerging candidates such as growth differentiation factor- 15 (GDF-15), have demonstrated diagnostic value in preeclampsia. However, their clinical utility for stillbirth prediction remains insufficiently validated. Prospective studies involving dedicated stillbirth cohorts are essential to establish their predictive performance and facilitate translation into routine clinical practice.</p>","PeriodicalId":45941,"journal":{"name":"Current Hypertension Reviews","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2026-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148946042","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}